Key result
Neuromuscular electrical stimulation added to cardiac rehab fails to improve exercise tolerance or quality of life.
Why the study?
The study was conducted to compare the effect of an exercise-based cardiac rehabilitation program alone versus combined with lower extremity neuromuscular electrical stimulation on the recovery of patients with chronic heart failure.
Does adding lower extremity neuromuscular electrical stimulation (NMES) to exercise-based cardiac rehabilitation improve exercise tolerance and quality of life in patients with stable chronic heart failure (NYHA II-III)?
RCT (n=72)
Does adding lower extremity neuromuscular electrical stimulation (NMES) to exercise-based cardiac rehabilitation improve exercise tolerance and quality of life in patients with stable chronic heart failure (NYHA II-III)?
Adding neuromuscular electrical stimulation to standard exercise-based cardiac rehabilitation does not provide additional benefits in exercise tolerance or quality of life for patients with stable NYHA II-III heart failure.
Answers are grounded in this paper and cite their sources.
NMES adds no benefit to exercise-based rehabilitation in stable HF; confirms exercise alone suffices for tolerance and QoL gains.
The study compares the effect of an exercise-based cardiac rehabilitation program with a program combining physical exercise and lower extremity neuromuscular electrical stimulation (NMES) on the recovery of patients with chronic heart failure (CHF) with NYHA II-III symptoms. Seventy two patients with stable CHF were randomly distributed to four groups that received exercise-based cardiac rehabilitation and pharmacological treatment. Groups I and II were additionally administered NMES (35 Hz and 10 Hz, respectively) and in Group III sham NMES was applied. Group IV (controls) received solely pharmacological and exercise treatment. Exercise tolerance and quality of life were assessed in patients pre-treatment and at week 3. Three weeks of rehabilitation induced significant increases (p < 0.05) in the distance covered in the 6-minute walk test, the metabolic equivalent (MET), the duration of the treadmill exercise stress test, the left ventricle ejection fraction (LVEF) and improved quality of life in all groups, but between-group differences were not significant (p > 0.05). In none of the groups were the left ventricle end-systolic and end-diastolic diameters (mm) measured at week 3 significantly different from their baseline values (p > 0.05). Exercise-based cardiac rehabilitation contributed to higher exercise tolerance, LVEF and quality of life of CHF patients (NYHA II-III), contrary to cardiac rehabilitation combined with lower extremity NMES (35 Hz and 10 Hz) that failed to induce such improvements. More research is necessary to assess the therapeutic efficacy of NMES applied to CHF patients with NYHA IV symptoms.
No takes yet. Share an insight, caveat, or question.
Kucio et al. (2018) conducted an RCT in Chronic heart failure (NYHA II-III) (n=72). Neuromuscular electrical stimulation (NMES) plus exercise-based cardiac rehabilitation vs. Sham NMES or solely pharmacological and exercise treatment was evaluated on Exercise tolerance and quality of life (p=>0.05). Neuromuscular electrical stimulation added to exercise-based cardiac rehabilitation did not improve exercise tolerance or quality of life compared to rehabilitation alone.
Synapse has enriched 10 related papers. Consider them for comparative context: